FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Bracco Diagnostics Multihance Multipack Recall

Multihance Multipack (gadobenate dimeglumine) injection, 529 mg/mL, Pharmacy Bulk Packa…

Bracco Diagnostics Inc · Monroe Township, NJ

Risk level
Class II
Reported by FDA
Sep 5, 2012
Recall ID
D-1665-2012
Check your lot numberHow we source this data

Summary

Bracco Diagnostics recalled Multihance Multipack starting Apr 16, 2012. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1665-2012 on Sep 5, 2012. Reason: Lack of Assurance of Sterility; Product recalled due to displacement of the aluminum crimp cap during product usage. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility; Product recalled due to displacement of the aluminum crimp cap during product usage.

Product description

Multihance Multipack (gadobenate dimeglumine) injection, 529 mg/mL, Pharmacy Bulk Package - Not for Direct Infusion, For Intravenous Use, Rx only, a) 50 mL Single Dose Vial, b) 100 mL Single Dose Vial, Manufactured for: Bracco Diagnostics Inc. Princeton, NJ 08543 by Nycomed GmbH, 78224 Singen (Germany), NDC a) 0270-5264-16, b) 0270-5264-17.

Lot numbers, UPCs & expiration codes

Lot #: a) 9J37457, 9J44058, Exp 10/12; b) 9I28973, Exp 09/12

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1665-2012
Classification
Class II
Status
Terminated
Recall initiated
Apr 16, 2012
FDA report date
Sep 5, 2012
Quantity
4,870 Vials
Recall type
Voluntary: Firm initiated
Recalling firm
Bracco Diagnostics Inc

Original FDA data

Every field from FDA enforcement report D-1665-2012, exactly as published.

Show all FDA fields
City
Monroe Township
State
NJ
Status
Terminated
Country
United States
Event ID
62735
Address
259 Prospect Plains Rd.
Address (line 2)
Building H
Code information
Lot #: a) 9J37457, 9J44058, Exp 10/12; b) 9I28973, Exp 09/12
Postal code
08831
Report date
Sep 5, 2012
Product type
Drugs
Recall number
D-1665-2012
Classification
Class II
Recalling firm
Bracco Diagnostics Inc
Product quantity
4,870 Vials
Termination date
Nov 13, 2013
Reason for recall
Lack of Assurance of Sterility; Product recalled due to displacement of the aluminum crimp cap during product usage.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Multihance Multipack (gadobenate dimeglumine) injection, 529 mg/mL, Pharmacy Bulk Package - Not for Direct Infusion, For Intravenous Use, Rx only, a) 50 mL Single Dose Vial, b) 100 mL Single Dose Vial, Manufactured for: Bracco Diagnostics Inc. Princeton, NJ 08543 by Nycomed GmbH, 78224 Singen (Germany), NDC a) 0270-5264-16, b) 0270-5264-17.
Distribution pattern
Nationwide
Recall initiation date
Apr 16, 2012
Initial firm notification
Letter
Center classification date
Aug 28, 2012

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1665-2012, published Sep 5, 2012. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls